Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 201

1.

Thinking Carefully About Marijuana Legalization: Public Health Considerations for State Policy Makers.

Robertson AG, Swartz MS.

Psychiatr Serv. 2019 May 6:appips201900124. doi: 10.1176/appi.ps.201900124. [Epub ahead of print] No abstract available.

PMID:
31056004
2.

Criminal Justice and Suicide Outcomes with Indiana's Risk-Based Gun Seizure Law.

Swanson JW, Easter MM, Alanis-Hirsch K, Belden CM, Norko MA, Robertson AG, Frisman LK, Lin HJ, Swartz MS, Parker GF.

J Am Acad Psychiatry Law. 2019 Apr 15. pii: JAAPL.003835-19. doi: 10.29158/JAAPL.003835-19. [Epub ahead of print]

PMID:
30988021
3.

Heterogeneity of Treatment Effects of Long-Acting Injectable Antipsychotic Medications.

Stroup TS, Bareis NA, Rosenheck RA, Swartz MS, McEvoy JP.

J Clin Psychiatry. 2018 Nov 27;80(1). pii: 18m12109. doi: 10.4088/JCP.18m12109.

PMID:
30549494
4.

Update on Assisted Outpatient Treatment.

Cripps SN, Swartz MS.

Curr Psychiatry Rep. 2018 Oct 13;20(12):112. doi: 10.1007/s11920-018-0982-z. Review.

PMID:
30315433
5.

Medication-Assisted Treatment for Alcohol-Dependent Adults With Serious Mental Illness and Criminal Justice Involvement: Effects on Treatment Utilization and Outcomes.

Robertson AG, Easter MM, Lin H, Frisman LK, Swanson JW, Swartz MS.

Am J Psychiatry. 2018 Jul 1;175(7):665-673. doi: 10.1176/appi.ajp.2018.17060688.

6.

Associations between pharmacotherapy for opioid dependence and clinical and criminal justice outcomes among adults with co-occurring serious mental illness.

Robertson AG, Easter MM, Lin HJ, Frisman LK, Swanson JW, Swartz MS.

J Subst Abuse Treat. 2018 Mar;86:17-25. doi: 10.1016/j.jsat.2017.12.003. Epub 2017 Dec 12.

7.

Randomised controlled trials and outpatient commitment.

Swartz MS, Swanson JW.

Lancet Psychiatry. 2017 Dec;4(12):e30. doi: 10.1016/S2215-0366(17)30443-1. No abstract available.

PMID:
29179941
8.

Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States.

Wu LT, Zhu H, Mannelli P, Swartz MS.

Drug Alcohol Depend. 2017 Aug 1;177:153-162. doi: 10.1016/j.drugalcdep.2017.03.037. Epub 2017 May 29.

9.

Facilitation of Psychiatric Advance Directives by Peers and Clinicians on Assertive Community Treatment Teams.

Easter MM, Swanson JW, Robertson AG, Moser LL, Swartz MS.

Psychiatr Serv. 2017 Jul 1;68(7):717-723. doi: 10.1176/appi.ps.201600423. Epub 2017 Apr 3.

PMID:
28366114
10.

Extended-release naltrexone and drug treatment courts: Policy and evidence for implementing an evidence-based treatment.

Robertson AG, Swartz MS.

J Subst Abuse Treat. 2018 Feb;85:101-104. doi: 10.1016/j.jsat.2017.02.016. Epub 2017 Feb 28.

PMID:
28274648
11.

Alternatives to the Emergency Department: In Reply.

Swartz MS.

Psychiatr Serv. 2017 Mar 1;68(3):307. doi: 10.1176/appi.ps.68205. No abstract available.

PMID:
28240153
12.

Victimization of persons with severe mental illness: a pressing global health problem.

Swartz MS, Bhattacharya S.

World Psychiatry. 2017 Feb;16(1):26-27. doi: 10.1002/wps.20393. No abstract available.

13.

Leading indicators of community-based violent events among adults with mental illness.

Van Dorn RA, Grimm KJ, Desmarais SL, Tueller SJ, Johnson KL, Swartz MS.

Psychol Med. 2017 May;47(7):1179-1191. doi: 10.1017/S0033291716003160. Epub 2016 Dec 21.

PMID:
27998319
14.

Treatment utilization among persons with opioid use disorder in the United States.

Wu LT, Zhu H, Swartz MS.

Drug Alcohol Depend. 2016 Dec 1;169:117-127. doi: 10.1016/j.drugalcdep.2016.10.015. Epub 2016 Oct 19.

15.

Emergency Department Boarding: Nowhere Else to Go.

Swartz MS.

Psychiatr Serv. 2016 Nov 1;67(11):1163. No abstract available.

PMID:
27799026
16.

Involuntary Outpatient Commitment and the Elusive Pursuit of Violence Prevention.

Swartz MS, Bhattacharya S, Robertson AG, Swanson JW.

Can J Psychiatry. 2017 Feb;62(2):102-108. doi: 10.1177/0706743716675857. Epub 2016 Oct 25. Review.

17.

A longitudinal analysis of the overlap between violence and victimization among adults with mental illnesses.

Johnson KL, Desmarais SL, Tueller SJ, Grimm KJ, Swartz MS, Van Dorn RA.

Psychiatry Res. 2016 Dec 30;246:203-210. doi: 10.1016/j.psychres.2016.09.039. Epub 2016 Sep 26.

18.

The latent structure of psychiatric symptoms across mental disorders as measured with the PANSS and BPRS-18.

Van Dorn RA, Desmarais SL, Grimm KJ, Tueller SJ, Johnson KL, Sellers BG, Swartz MS.

Psychiatry Res. 2016 Nov 30;245:83-90. doi: 10.1016/j.psychres.2016.08.029. Epub 2016 Aug 9.

19.

Trends in cannabis use disorders among racial/ethnic population groups in the United States.

Wu LT, Zhu H, Swartz MS.

Drug Alcohol Depend. 2016 Aug 1;165:181-90. doi: 10.1016/j.drugalcdep.2016.06.002. Epub 2016 Jun 8.

20.

Gun Violence, Mental Illness, And Laws That Prohibit Gun Possession: Evidence From Two Florida Counties.

Swanson JW, Easter MM, Robertson AG, Swartz MS, Alanis-Hirsch K, Moseley D, Dion C, Petrila J.

Health Aff (Millwood). 2016 Jun 1;35(6):1067-75. doi: 10.1377/hlthaff.2016.0017.

21.

Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia.

Rosenheck RA, Leslie DL, Sint KJ, Lin H, Li Y, McEvoy JP, Byerly MJ, Hamer RM, Swartz MS, Stroup TS.

Psychiatr Serv. 2016 Oct 1;67(10):1124-1130. Epub 2016 Jun 1.

22.

A Randomized Clinical Trial of a Money Management Intervention for Veterans With Psychiatric Disabilities.

Elbogen EB, Hamer RM, Swanson JW, Swartz MS.

Psychiatr Serv. 2016 Oct 1;67(10):1142-1145. Epub 2016 May 16.

PMID:
27181733
23.

Mental Health Courts: Does Treatment Make a Difference?

Swartz MS, Robertson AG.

Psychiatr Serv. 2016 Apr 1;67(4):363. doi: 10.1176/appi.ps.670403. No abstract available.

24.

Proximal Risk Factors for Short-Term Community Violence Among Adults With Mental Illnesses.

Johnson KL, Desmarais SL, Grimm KJ, Tueller SJ, Swartz MS, Van Dorn RA.

Psychiatr Serv. 2016 Jul 1;67(7):771-8. doi: 10.1176/appi.ps.201500259. Epub 2016 Feb 29.

25.

Increasing Access to State Psychiatric Hospital Beds: Exploring Supply-Side Solutions.

La EM, Lich KH, Wells R, Ellis AR, Swartz MS, Zhu R, Morrissey JP.

Psychiatr Serv. 2016 May 1;67(5):523-8. doi: 10.1176/appi.ps.201400570. Epub 2015 Dec 1.

PMID:
26620287
26.

Consideration of all evidence about community treatment orders.

Swartz MS, Swanson JW.

Lancet Psychiatry. 2015 Oct;2(10):852-3. doi: 10.1016/S2215-0366(15)00364-8. Epub 2015 Sep 8. No abstract available.

PMID:
26362497
27.

Influence of Criminal Justice Involvement and Psychiatric Diagnoses on Treatment Costs Among Adults With Serious Mental Illness.

Robertson AG, Swanson JW, Lin H, Easter MM, Frisman LK, Swartz MS.

Psychiatr Serv. 2015 Sep;66(9):907-9. doi: 10.1176/appi.ps.201500134. Epub 2015 May 15.

28.

Emergency Psychiatry Experience, Resident Burnout, and Future Plans to Treat Publicly Funded Patients.

Dennis NM, Swartz MS.

Psychiatr Serv. 2015 Aug 1;66(8):892-5. doi: 10.1176/appi.ps.201400234. Epub 2015 Apr 15.

PMID:
25873026
29.

Guns, Impulsive Angry Behavior, and Mental Disorders: Results from the National Comorbidity Survey Replication (NCS-R).

Swanson JW, Sampson NA, Petukhova MV, Zaslavsky AM, Appelbaum PS, Swartz MS, Kessler RC.

Behav Sci Law. 2015 Jun;33(2-3):199-212. doi: 10.1002/bsl.2172. Epub 2015 Apr 8.

30.

Perceived cannabis use norms and cannabis use among adolescents in the United States.

Wu LT, Swartz MS, Brady KT, Hoyle RH; NIDA AAPI Workgroup.

J Psychiatr Res. 2015 May;64:79-87. doi: 10.1016/j.jpsychires.2015.02.022. Epub 2015 Mar 6.

31.

Latent class analysis of discordance between results of drug use assessments in the CATIE data.

Johnson KL, Desmarais SL, Swartz MS, Van Dorn RA.

Schizophr Res. 2015 Feb;161(2-3):434-8. doi: 10.1016/j.schres.2014.11.016. Epub 2014 Dec 1.

32.

Treatment participation and medication adherence: effects on criminal justice costs of persons with mental illness.

Robertson AG, Swanson JW, Van Dorn RA, Swartz MS.

Psychiatr Serv. 2014 Oct;65(10):1189-91. doi: 10.1176/appi.ps.201400247.

PMID:
25270494
33.

Nonmedical stimulant use among young Asian-Americans, Native Hawaiians/Pacific Islanders, and mixed-race individuals aged 12-34 years in the United States.

Wu LT, Swartz MS, Brady KT, Blazer DG, Hoyle RH; NIDA AAPI Workgroup.

J Psychiatr Res. 2014 Dec;59:189-99. doi: 10.1016/j.jpsychires.2014.09.004. Epub 2014 Sep 16.

34.

How do mental health courts work?

Swartz MS.

Psychiatr Serv. 2014 Sep 1;65(9):1077. doi: 10.1176/appi.ps.650902. No abstract available.

PMID:
25179182
35.

Cortical surface anatomy in pediatric patients with generalized anxiety disorder.

Strawn JR, John Wegman C, Dominick KC, Swartz MS, Wehry AM, Patino LR, Strakowski SM, Adler CM, Eliassen JC, DelBello MP.

J Anxiety Disord. 2014 Oct;28(7):717-23. doi: 10.1016/j.janxdis.2014.07.012. Epub 2014 Aug 12.

PMID:
25155256
36.

The effects of state psychiatric hospital waitlist policies on length of stay and time to readmission.

Holdsworth La E, Zhu R, Hassmiller Lich K, Ellis AR, Swartz MS, Kosorok MR, Morrissey JP.

Adm Policy Ment Health. 2015 May;42(3):332-42. doi: 10.1007/s10488-014-0573-1.

37.

Why the evidence for outpatient commitment is good enough.

Swanson JW, Swartz MS.

Psychiatr Serv. 2014 Jun 1;65(6):808-11. doi: 10.1176/appi.ps.201300424.

PMID:
24881685
38.

Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial.

McEvoy JP, Byerly M, Hamer RM, Dominik R, Swartz MS, Rosenheck RA, Ray N, Lamberti JS, Buckley PF, Wilkins TM, Stroup TS.

JAMA. 2014 May 21;311(19):1978-87. doi: 10.1001/jama.2014.4310. Erratum in: JAMA. 2014 Oct 8;312(14):1473.

39.

Mental health and reoffending outcomes of jail diversion participants with a brief incarceration after arraignment.

Robertson AG, Lin HJ, Frisman LK, Petrila J, Swartz MS.

Psychiatr Serv. 2014 Sep 1;65(9):1113-9. doi: 10.1176/appi.ps.201300286.

PMID:
24828832
40.

Patterns of justice involvement among adults with schizophrenia and bipolar disorder: key risk factors.

Robertson AG, Swanson JW, Frisman LK, Lin H, Swartz MS.

Psychiatr Serv. 2014 Jul;65(7):931-8. doi: 10.1176/appi.ps.201300044.

PMID:
24633645
41.

Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: a very low dose naltrexone and buprenorphine open label trial.

Mannelli P, Wu LT, Peindl KS, Swartz MS, Woody GE.

Drug Alcohol Depend. 2014 May 1;138:83-8. doi: 10.1016/j.drugalcdep.2014.02.002. Epub 2014 Feb 15.

42.

Community violence perpetration and victimization among adults with mental illnesses.

Desmarais SL, Van Dorn RA, Johnson KL, Grimm KJ, Douglas KS, Swartz MS.

Am J Public Health. 2014 Dec;104(12):2342-9. doi: 10.2105/AJPH.2013.301680. Epub 2014 Feb 13.

43.

Letter to the editor: Critique of Bahorik et al. (2013)--'Under-reporting of drug use among individuals with schizophrenia: prevalence and predictors'.

Van Dorn RA, Desmarais SL, Swartz MS, Young MS, Sellers BG.

Psychol Med. 2014 Feb;44(3):668-70. doi: 10.1017/S0033291713002511. Epub 2013 Oct 28. No abstract available.

44.

Comorbid substance use disorders with other Axis I and II mental disorders among treatment-seeking Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race people.

Wu LT, Blazer DG, Gersing KR, Burchett B, Swartz MS, Mannelli P; NIDA AAPI Workgroup.

J Psychiatr Res. 2013 Dec;47(12):1940-8. doi: 10.1016/j.jpsychires.2013.08.022. Epub 2013 Sep 9.

45.

DEER EPR measurements for membrane protein structures via bifunctional spin labels and lipodisq nanoparticles.

Sahu ID, McCarrick RM, Troxel KR, Zhang R, Smith HJ, Dunagan MM, Swartz MS, Rajan PV, Kroncke BM, Sanders CR, Lorigan GA.

Biochemistry. 2013 Sep 24;52(38):6627-32. doi: 10.1021/bi4009984. Epub 2013 Sep 9.

46.

The cost of assisted outpatient treatment: can it save states money?

Swanson JW, Van Dorn RA, Swartz MS, Robbins PC, Steadman HJ, McGuire TG, Monahan J.

Am J Psychiatry. 2013 Dec;170(12):1423-32. doi: 10.1176/appi.ajp.2013.12091152. Erratum in: Am J Psychiatry. 2013 Oct 1;170(10):1218. Am J Psychiatry. 2013 Dec 1;170(12):1499.

PMID:
23896998
47.

Illicit and nonmedical drug use among Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race individuals.

Wu LT, Blazer DG, Swartz MS, Burchett B, Brady KT; NIDA AAPI Workgroup.

Drug Alcohol Depend. 2013 Dec 1;133(2):360-7. doi: 10.1016/j.drugalcdep.2013.06.008. Epub 2013 Jul 23.

48.

Drug and alcohol trajectories among adults with schizophrenia: data from the CATIE study.

Van Dorn RA, Desmarais SL, Tueller SJ, Jolley JM, Johnson KL, Swartz MS.

Schizophr Res. 2013 Aug;148(1-3):126-9. doi: 10.1016/j.schres.2013.05.006. Epub 2013 May 29.

49.

Comparison of outcomes for African Americans, Hispanics, and Non-Hispanic Whites in the CATIE study.

Arnold JG, Miller AL, CaƱive JM, Rosenheck RA, Swartz MS, Mintz J.

Psychiatr Serv. 2013 Jun;64(6):570-8. doi: 10.1176/appi.ps.002412012.

PMID:
23494108
50.

Costs of criminal justice involvement among persons with serious mental illness in connecticut.

Swanson JW, Frisman LK, Robertson AG, Lin HJ, Trestman RL, Shelton DA, Parr K, Rodis E, Buchanan A, Swartz MS.

Psychiatr Serv. 2013 Jul 1;64(7):630-7. doi: 10.1176/appi.ps.002212012.

PMID:
23494058

Supplemental Content

Loading ...
Support Center